Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...

"You could make it redder if you wanted to." PepsiCo sparks industry shake-up with daring twist on iconic snack: 'It's really ...

The U.S. Food and Drug Administration on Friday approved Sanofi SA’s (NASDAQ:SNY) Qfitlia (fitusiran), the first antithrombin ...

New York City’s waste reduction efforts will commence a new phase on Tuesday, as the city’s sanitation agency will begin ...

Transcend also saw significant improvements on secondary endpoints that assessed the rate of response, remission and loss of ...

AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.

The U.S. Food and Drug Administration (FDA) informed the company that an expanded access protocol for NVG-291 may proceedThis ...

In December 2024, Elicio announced the completion of enrollment of the randomized Phase 2 AMPLIFY-7P clinical trial ( ...

The total net revenue for the year ended December 31, 2024 of approximately $11.7 million for prescription and non-prescription products, including license revenue, increased approximately 20% versus ...

BX211 was safe and well-toleratedBX211 produced sustained and statistically significant1 Percent Area Reduction (PAR) of ulcer size (p = 0.046 at ...

Eli Lilly on Sunday said the Phase 2 study of lepodisiran, designed to lower the production of lipoprotein (a), or lp (a), met its primary endpoint, reducing lp (a) levels by an average of 93.9% over ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.